MR编号 | DK/H/3117/001 |
---|
药品名称 | Clobazam Essential Pharmaceuticals |
---|
活性成分 | |
---|
剂型 | Oral suspension |
---|
上市许可持有人 | Essential Pharmaceuticals Limited
Vision Exchange Building, Triq It-Territorjals Zone 1, Central Business District
CBD 1070 Birkirkara
Malta |
---|
参考成员国 - 产品名称 | Denmark (DK) |
---|
互认成员国 - 产品名称 | - Belgium (BE)
Clobazam Essential Pharmaceuticals 1 mg/ml suspension buvable - Netherlands (NL)
- Luxembourg (LU)
- Ireland (IE)
- Austria (AT)
Clobazam Essential Pharmaceuticals 1 mg/ml Suspension zum Einnehmen - Norway (NO)
Clobazam Essential Pharmaceuticals - United Kingdom (Northern Ireland) (XI)
|
---|
许可日期 | 2021/08/19 |
---|
最近更新日期 | 2024/11/14 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|